CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
BIRD-C is developing a novel cancer immunotherapy using Bacterial Ghosts to stimulate the immune system against tumors. This personalized medicine approach aims to improve patient outcomes and address the challenges of cancer treatment.
MMalignant diseases represent a major health problem in all parts of the world and their incidence, according to the WHO/IARC World Cancer Report 2014, will increase by 57% worldwide in the next 20 years.
Standard treatment strategies forcancer including surgery, chemotherapy and targeted molecular therapy still do not guarantee complete elimination of thedisease.
In addition, cancer cells exhibited high capability to escape from immunosurveillance after applied treatment whichwas confirmed with…
BIOTECH INNOVATION RESEARCH DEVELOPMENT AND CONSULTING GMBH & CO KG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
